Exagen announces acceptance of multiple abstracts at acr 2023 annual meeting

San diego, california, sept. 28, 2023 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, announced today the acceptance of five abstracts at the 2023 american college of rheumatology's (acr) annual meeting, acr convergence 2023, being held november 10-15, 2023, at the san diego convention center in san diego, california.

XGN Ratings Summary

XGN Quant Ranking